Kaleido Biosciences, Inc.
KLDO · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $38 | $46 | $71 | $76 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $2 | $2 | $0 |
| Total Curr. Assets | $42 | $49 | $73 | $76 |
| Property Plant & Equip (Net) | $6 | $8 | $7 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $2 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $5 | $0 | $4 |
| Total NC Assets | $8 | $13 | $9 | $9 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $50 | $59 | $82 | $85 |
| Liabilities | – | – | – | – |
| Payables | $6 | $5 | $2 | $3 |
| Short-Term Debt | $16 | $3 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $0 | $7 | $7 |
| Other Curr. Liab. | $7 | $8 | $1 | $8 |
| Total Curr. Liab. | $30 | $17 | $10 | $11 |
| LT Debt | $6 | $18 | $20 | $15 |
| Deferred Rev, NC | -$0 | -$0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $3 | $1 |
| Total NC Liab. | $10 | $22 | $23 | $16 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $40 | $39 | $33 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $82 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$364 | -$274 | -$193 | -$106 |
| AOCI | $0 | $0 | -$82 | -$1 |
| Other Equity | $375 | $295 | $241 | $164 |
| Total Equity | $11 | $20 | $49 | $58 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $50 | $59 | $82 | $85 |
| Net Debt | -$17 | -$25 | -$51 | -$61 |